| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-08 |
| mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
8e-07 |
| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |